Results 111 to 120 of about 73,510 (193)

Ca2+ - Induced Structural Change of Multi-Domain Collagen Binding Segments of Collagenases ColG and ColH from Hathewaya histolytica [PDF]

, 2018
Hathewaya histolytica, previously renamed as Clostridium histolyticum, secretes at least two collagenases, ColH and ColG, that allow for degradation of extracellular matrices of animal tissue.
Ruth, Christopher Eric
core   +2 more sources

[Isolated Polycystic Liver Disease].

Acta medica portuguesa, 2017
N/A.
Rita Seara Costa, Bruno Gonçalves, Ana Isabel Rebelo   +2 more
openaire   +2 more sources

Relevance of ultrasound examination in general practice. A case report of a patient with autosomal dominant polycystic kidney disease

Journal of Ultrasonography, 2013
Autosomal dominant polycystic kidney disease is a genetic disorder which results in the development of multiple cysts in the kidneys and other parenchymal organs. The two genes in which mutations are known to cause autosomal dominant polycystic kidney
Izabela Cwojdzińska-Jankowska, Anna Plewa   +1 more
doaj  

G-protein signaling modulator 1 deficiency accelerates cystic disease in an orthologous mouse model of autosomal dominant polycystic kidney disease [PDF]

, 2012
Michelle Kwon, Tengis S. Pavlov, Kandai Nozu, Shauna A. Rasmussen, Daria V. Ilatovskaya, Alexandra Lerch‐Gaggl, Lauren M. North, Hyunho Kim, Feng Qian, William E. Sweeney, Ellis D. Avner, J Blumer, Alexander Staruschenko, Frank Park   +13 more
openalex   +1 more source

Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy

, 2013
Isaline Rowe, Marco Chiaravalli, Valeria Mannella, Valeria Ulisse, Giacomo Quilici, Monika Pema, Xuewen Song, Hangxue Xu, Silvia Mari, Feng Qian, York Pei, Giovanna Musco, Alessandra Boletta   +12 more
openalex   +1 more source

Lysophosphatidic Acid is a Modulator of Cyst Growth in Autosomal Dominant Polycystic Kidney Disease [PDF]

, 2011
Bonnie L. Blazer‐Yost, Brenda J. Blacklock, Stephanie Flaig, Robert L. Bacallao, Vincent H. Gattone   +4 more
openalex   +1 more source

Portal hypertension syndrome in children with autosomal recessive polycystic kidney disease with liver cysts and hepatic fibrosis

, 2023
Э. Ф. Андреева, I. V. Dyug, L. G. Goryacheva, Н. Д. Савенкова   +3 more
openalex   +2 more sources

Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease. [PDF]

, 2018
Autosomal dominant polycystic kidney disease (ADPKD) is a widespread genetic disease that leads to renal failure in the majority of patients. The very first pharmacological treatment, tolvaptan, received Food and Drug Administration approval in 2018 ...
Bourgeois, Bryan C, Kruger, Samantha L, Shillingford, Jonathan M, Torres, Jacob, Weimbs, Thomas   +4 more
core   +1 more source

Progressive Loss of Renal Function Is an Age-Dependent Heritable Trait in Type 1 Autosomal Dominant Polycystic Kidney Disease

, 2005
Andrew D. Paterson, Riccardo Magistroni, Ning He, Kairong Wang, Margaret Johnson, Pamela R. Fain, Elizabeth Dicks, Patrick S. Parfrey, Peter St George‐Hyslop, York Pei   +9 more
openalex   +2 more sources

Elamipretide treatment during pregnancy ameliorates the progression of polycystic kidney disease in maternal and neonatal mice with PKD1 mutations

, 2021
Nastaran Daneshgar, Peir‐In Liang, Renny S. Lan, McKenna M. Horstmann, Lindsay Pack, Gourav Bhardwaj, Christie M. Penniman, Brian T. O’Neill, Dao‐Fu Dai   +8 more
openalex   +2 more sources